L-threonine
GeneID | Mean_1 | Mean_3 | StDev_1 | StDev_3 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 19 | 3.0 | 2.4 | 0.6 | 0.1 | -1.605 | 0.2442 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
2 | 52 | 9.4 | 9.8 | 0.2 | 0.1 | 2.649 | 0.0733 | ACP1 | acid phosphatase 1, soluble |
3 | 53 | 7.1 | 6.8 | 0.3 | 0.3 | -1.081 | 0.3404 | ACP2 | acid phosphatase 2, lysosomal |
4 | 156 | 11.4 | 11.9 | 0.1 | 0.2 | 4.976 | 0.0192 | ADRBK1 | adrenergic, beta, receptor kinase 1 |
5 | 174 | 2.4 | 2.4 | 0.0 | 0.0 | -0.287 | 0.7900 | AFP | alpha-fetoprotein |
6 | 183 | 2.4 | 2.4 | 0.1 | 0.0 | -1.120 | 0.3647 | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
7 | 231 | 2.7 | 5.8 | 0.3 | 0.1 | 16.078 | 0.0023 | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) |
8 | 213 | 3.2 | 2.8 | 0.4 | 0.5 | -1.148 | 0.3190 | ALB | albumin |
9 | 348 | 11.5 | 11.2 | 0.3 | 0.3 | -1.524 | 0.2038 | APOE | apolipoprotein E |
10 | 351 | 10.8 | 10.5 | 0.1 | 0.3 | -1.679 | 0.1960 | APP | amyloid beta (A4) precursor protein |
11 | 353 | 16.3 | 16.0 | 0.1 | 0.1 | -5.812 | 0.0044 | APRT | adenine phosphoribosyltransferase |
12 | 80150 | 7.9 | 9.9 | 0.3 | 0.1 | 12.033 | 0.0014 | ASRGL1 | asparaginase like 1 |
13 | 472 | 6.0 | 5.6 | 0.4 | 0.1 | -1.710 | 0.2236 | ATM | ATM serine/threonine kinase |
14 | 478 | 8.5 | 8.2 | 0.2 | 0.2 | -1.467 | 0.2185 | ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide |
15 | 481 | 10.2 | 13.5 | 0.2 | 0.1 | 24.123 | 0.0000 | ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide |
16 | 495 | 2.4 | 2.5 | 0.0 | 0.3 | 1.019 | 0.4140 | ATP4A | ATPase, H+/K+ exchanging, alpha polypeptide |
17 | 51761 | 2.8 | 4.2 | 0.2 | 0.2 | 8.068 | 0.0017 | ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 |
18 | 545 | 10.1 | 9.9 | 0.1 | 0.1 | -3.070 | 0.0385 | ATR | ATR serine/threonine kinase |
19 | 9212 | 8.7 | 10.0 | 0.2 | 0.2 | 7.824 | 0.0014 | AURKB | aurora kinase B |
20 | 6795 | 2.3 | 2.2 | 0.1 | 0.0 | -0.879 | 0.4595 | AURKC | aurora kinase C |
21 | 596 | 10.3 | 10.3 | 0.2 | 0.1 | 0.739 | 0.5268 | BCL2 | B-cell CLL/lymphoma 2 |
22 | 836 | 8.2 | 8.0 | 0.3 | 0.2 | -1.211 | 0.3082 | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
23 | 842 | 8.6 | 7.7 | 0.1 | 0.6 | -2.444 | 0.1304 | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
24 | 859 | 2.5 | 3.2 | 0.1 | 0.1 | 7.101 | 0.0028 | CAV3 | caveolin 3 |
25 | 891 | 11.3 | 12.0 | 0.1 | 0.2 | 4.535 | 0.0280 | CCNB1 | cyclin B1 |
26 | 998 | 9.1 | 9.3 | 0.1 | 0.2 | 1.458 | 0.2264 | CDC42 | cell division cycle 42 |
27 | 1000 | 3.2 | 3.2 | 0.4 | 0.1 | 0.188 | 0.8677 | CDH2 | cadherin 2, type 1, N-cadherin (neuronal) |
28 | 983 | 11.2 | 11.9 | 0.1 | 0.4 | 2.668 | 0.0952 | CDK1 | cyclin-dependent kinase 1 |
29 | 1017 | 8.1 | 8.8 | 0.1 | 0.3 | 3.237 | 0.0750 | CDK2 | cyclin-dependent kinase 2 |
30 | 1020 | 10.8 | 11.6 | 0.1 | 0.0 | 8.569 | 0.0126 | CDK5 | cyclin-dependent kinase 5 |
31 | 1029 | 6.0 | 6.5 | 0.4 | 0.0 | 2.330 | 0.1427 | CDKN2A | cyclin-dependent kinase inhibitor 2A |
32 | 11200 | 10.1 | 10.1 | 0.1 | 0.1 | -0.348 | 0.7495 | CHEK2 | checkpoint kinase 2 |
33 | 83548 | 10.1 | 10.1 | 0.0 | 0.2 | 0.698 | 0.5574 | COG3 | component of oligomeric golgi complex 3 |
34 | 23406 | 11.1 | 11.2 | 0.3 | 0.1 | 0.666 | 0.5703 | COTL1 | coactosin-like F-actin binding protein 1 |
35 | 1414 | 2.4 | 2.9 | 0.0 | 0.9 | 1.038 | 0.4081 | CRYBB1 | crystallin, beta B1 |
36 | 1437 | 2.3 | 2.3 | 0.0 | 0.0 | 0.420 | 0.7020 | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
37 | 1447 | 2.3 | 2.5 | 0.0 | 0.3 | 0.975 | 0.4313 | CSN2 | casein beta |
38 | 54205 | 10.8 | 10.8 | 0.4 | 0.3 | 0.041 | 0.9690 | CYCS | cytochrome c, somatic |
39 | 114757 | 13.4 | 13.0 | 0.1 | 0.2 | -2.755 | 0.0760 | CYGB | cytoglobin |
40 | 1555 | 5.2 | 5.5 | 0.3 | 0.1 | 1.601 | 0.2134 | CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 |
41 | 1558 | 2.2 | 2.8 | 0.0 | 0.6 | 1.477 | 0.2775 | CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 |
42 | 4921 | 2.6 | 2.9 | 0.4 | 0.4 | 0.964 | 0.3899 | DDR2 | discoidin domain receptor tyrosine kinase 2 |
43 | 1666 | 11.2 | 10.5 | 0.2 | 0.3 | -3.384 | 0.0309 | DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial |
44 | 1850 | 7.6 | 7.6 | 0.5 | 0.3 | -0.042 | 0.9688 | DUSP8 | dual specificity phosphatase 8 |
45 | 1859 | 7.0 | 7.1 | 0.0 | 0.1 | 2.545 | 0.0991 | DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
46 | 1915 | 15.6 | 15.3 | 0.1 | 0.2 | -2.175 | 0.1422 | EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 |
47 | 1938 | 15.4 | 15.0 | 0.2 | 0.2 | -2.546 | 0.0715 | EEF2 | eukaryotic translation elongation factor 2 |
48 | 30008 | 8.6 | 7.6 | 0.1 | 1.2 | -1.433 | 0.2872 | EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 |
49 | 1950 | 2.3 | 2.4 | 0.0 | 0.1 | 1.016 | 0.4144 | EGF | epidermal growth factor |
50 | 1956 | 2.9 | 3.3 | 0.2 | 0.1 | 3.112 | 0.0782 | EGFR | epidermal growth factor receptor |
51 | 1978 | 13.9 | 12.8 | 0.8 | 0.1 | -2.355 | 0.1388 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 |
52 | 1999 | 10.5 | 10.5 | 0.1 | 0.7 | 0.018 | 0.9875 | ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
53 | 2048 | 5.7 | 5.8 | 0.3 | 0.2 | 0.700 | 0.5288 | EPHB2 | EPH receptor B2 |
54 | 2064 | 9.7 | 9.0 | 0.4 | 0.3 | -2.344 | 0.0865 | ERBB2 | erb-b2 receptor tyrosine kinase 2 |
55 | 30816 | 2.2 | 2.3 | 0.0 | 0.1 | 1.462 | 0.2732 | ERVW-1 | endogenous retrovirus group W, member 1 |
56 | 2113 | 2.3 | 2.3 | 0.0 | 0.0 | 0.466 | 0.6664 | ETS1 | v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
57 | 2146 | 10.9 | 11.9 | 0.2 | 0.3 | 5.102 | 0.0126 | EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
58 | 2155 | 5.3 | 5.6 | 1.1 | 0.3 | 0.465 | 0.6832 | F7 | coagulation factor VII (serum prothrombin conversion accelerator) |
59 | 2158 | 2.3 | 2.3 | 0.0 | 0.0 | 0.072 | 0.9471 | F9 | coagulation factor IX |
60 | 144717 | 7.2 | 7.6 | 0.2 | 0.2 | 2.499 | 0.0694 | FAM109A | family with sequence similarity 109, member A |
61 | 55294 | 9.4 | 9.6 | 0.1 | 0.2 | 1.872 | 0.1411 | FBXW7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
62 | 2258 | 4.8 | 6.2 | 0.4 | 0.4 | 4.282 | 0.0135 | FGF13 | fibroblast growth factor 13 |
63 | 2309 | 11.3 | 10.7 | 0.1 | 0.2 | -5.665 | 0.0060 | FOXO3 | forkhead box O3 |
64 | 2645 | 4.8 | 4.7 | 0.1 | 0.2 | -0.602 | 0.5904 | GCK | glucokinase (hexokinase 4) |
65 | 2697 | 4.2 | 5.8 | 0.6 | 0.4 | 3.627 | 0.0336 | GJA1 | gap junction protein, alpha 1, 43kDa |
66 | 373156 | 11.3 | 12.3 | 0.1 | 0.2 | 8.215 | 0.0017 | GSTK1 | glutathione S-transferase kappa 1 |
67 | 3014 | 13.3 | 13.7 | 0.1 | 0.2 | 2.466 | 0.0809 | H2AFX | H2A histone family, member X |
68 | 3066 | 8.1 | 8.2 | 0.3 | 0.3 | 0.338 | 0.7523 | HDAC2 | histone deacetylase 2 |
69 | 8924 | 6.8 | 7.1 | 0.1 | 0.2 | 2.618 | 0.1049 | HERC2 | HECT and RLD domain containing E3 ubiquitin protein ligase 2 |
70 | 3098 | 12.0 | 11.8 | 0.2 | 0.1 | -1.634 | 0.1893 | HK1 | hexokinase 1 |
71 | 3242 | 3.6 | 3.5 | 0.4 | 0.4 | -0.326 | 0.7608 | HPD | 4-hydroxyphenylpyruvate dioxygenase |
72 | 3265 | 10.7 | 10.7 | 0.2 | 0.4 | -0.278 | 0.8001 | HRAS | Harvey rat sarcoma viral oncogene homolog |
73 | 8630 | 8.1 | 8.3 | 0.2 | 0.3 | 0.797 | 0.4756 | HSD17B6 | hydroxysteroid (17-beta) dehydrogenase 6 |
74 | 22858 | 9.7 | 9.8 | 0.1 | 0.2 | 1.356 | 0.2546 | ICK | intestinal cell (MAK-like) kinase |
75 | 3416 | 10.6 | 11.0 | 0.1 | 0.3 | 2.154 | 0.1364 | IDE | insulin-degrading enzyme |
76 | 8517 | 10.0 | 10.2 | 0.2 | 0.2 | 1.472 | 0.2152 | IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
77 | 3586 | 2.3 | 2.3 | 0.0 | 0.0 | 0.041 | 0.9698 | IL10 | interleukin 10 |
78 | 3558 | 2.5 | 2.4 | 0.1 | 0.1 | -0.771 | 0.4998 | IL2 | interleukin 2 |
79 | 246778 | 4.9 | 5.3 | 0.2 | 0.5 | 1.254 | 0.3133 | IL27 | interleukin 27 |
80 | 3569 | 2.3 | 2.3 | 0.0 | 0.0 | -0.440 | 0.6964 | IL6 | interleukin 6 |
81 | 3630 | 3.6 | 4.1 | 0.4 | 0.4 | 1.716 | 0.1617 | INS | insulin |
82 | 3643 | 8.3 | 9.3 | 0.1 | 0.2 | 8.564 | 0.0056 | INSR | insulin receptor |
83 | 3664 | 7.2 | 6.3 | 0.5 | 0.2 | -2.556 | 0.0934 | IRF6 | interferon regulatory factor 6 |
84 | 8471 | 2.5 | 2.5 | 0.1 | 0.1 | 0.106 | 0.9212 | IRS4 | insulin receptor substrate 4 |
85 | 51477 | 10.7 | 10.2 | 0.2 | 0.1 | -4.309 | 0.0207 | ISYNA1 | inositol-3-phosphate synthase 1 |
86 | 3728 | 14.2 | 13.5 | 0.2 | 0.2 | -4.400 | 0.0119 | JUP | junction plakoglobin |
87 | 3767 | 5.1 | 4.3 | 0.4 | 0.4 | -2.556 | 0.0635 | KCNJ11 | potassium channel, inwardly rectifying subfamily J, member 11 |
88 | 3835 | 9.8 | 10.1 | 0.2 | 0.2 | 1.400 | 0.2361 | KIF22 | kinesin family member 22 |
89 | 889 | 2.8 | 3.5 | 0.4 | 0.5 | 1.612 | 0.1885 | KRIT1 | KRIT1, ankyrin repeat containing |
90 | 3858 | 13.8 | 13.7 | 0.3 | 0.2 | -0.479 | 0.6620 | KRT10 | keratin 10, type I |
91 | 3856 | 12.3 | 13.0 | 0.1 | 0.1 | 10.763 | 0.0005 | KRT8 | keratin 8, type II |
92 | 3939 | 13.5 | 13.5 | 0.2 | 0.3 | 0.040 | 0.9697 | LDHA | lactate dehydrogenase A |
93 | 120892 | 2.4 | 2.3 | 0.1 | 0.0 | -0.719 | 0.5367 | LRRK2 | leucine-rich repeat kinase 2 |
94 | 6416 | 10.8 | 10.7 | 0.1 | 0.1 | -0.556 | 0.6107 | MAP2K4 | mitogen-activated protein kinase kinase 4 |
95 | 4214 | 11.6 | 11.1 | 0.1 | 0.1 | -4.921 | 0.0154 | MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
96 | 1432 | 7.8 | 7.5 | 0.3 | 0.2 | -1.540 | 0.2107 | MAPK14 | mitogen-activated protein kinase 14 |
97 | 5595 | 8.9 | 9.2 | 0.3 | 0.1 | 1.920 | 0.1525 | MAPK3 | mitogen-activated protein kinase 3 |
98 | 5599 | 6.5 | 6.4 | 0.2 | 0.1 | -0.806 | 0.4754 | MAPK8 | mitogen-activated protein kinase 8 |
99 | 4137 | 11.1 | 11.1 | 0.2 | 0.1 | -0.578 | 0.6155 | MAPT | microtubule-associated protein tau |
100 | 4170 | 10.3 | 10.6 | 0.4 | 0.3 | 1.170 | 0.3075 | MCL1 | myeloid cell leukemia 1 |
101 | 10724 | 12.0 | 11.9 | 0.3 | 0.5 | -0.288 | 0.7886 | MGEA5 | meningioma expressed antigen 5 (hyaluronidase) |
102 | 4323 | 3.3 | 3.9 | 0.1 | 0.5 | 1.867 | 0.1878 | MMP14 | matrix metallopeptidase 14 (membrane-inserted) |
103 | 4353 | 2.7 | 2.3 | 0.3 | 0.0 | -2.005 | 0.1812 | MPO | myeloperoxidase |
104 | 4477 | 5.5 | 9.1 | 0.6 | 0.1 | 10.135 | 0.0068 | MSMB | microseminoprotein, beta- |
105 | 4478 | 2.8 | 3.1 | 0.2 | 0.2 | 2.222 | 0.0907 | MSN | moesin |
106 | 92170 | 8.0 | 8.2 | 0.2 | 0.2 | 1.022 | 0.3647 | MTG1 | mitochondrial ribosome-associated GTPase 1 |
107 | 2475 | 8.9 | 9.1 | 0.0 | 0.1 | 3.319 | 0.0559 | MTOR | mechanistic target of rapamycin (serine/threonine kinase) |
108 | 4609 | 8.9 | 8.0 | 0.4 | 0.6 | -2.174 | 0.1053 | MYC | v-myc avian myelocytomatosis viral oncogene homolog |
109 | 4698 | 11.7 | 12.2 | 0.2 | 0.1 | 3.835 | 0.0232 | NDUFA5 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 |
110 | 51701 | 10.3 | 9.9 | 0.1 | 0.2 | -2.795 | 0.0788 | NLK | nemo-like kinase |
111 | 4841 | 13.3 | 13.1 | 0.2 | 0.3 | -1.037 | 0.3658 | NONO | non-POU domain containing, octamer-binding |
112 | 4868 | 3.4 | 2.8 | 1.2 | 0.3 | -0.746 | 0.5269 | NPHS1 | nephrosis 1, congenital, Finnish type (nephrin) |
113 | 4869 | 16.5 | 16.5 | 0.1 | 0.0 | 1.322 | 0.2951 | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
114 | 27065 | 2.1 | 2.1 | 0.0 | 0.0 | 0.372 | 0.7400 | NSG1 | neuron specific gene family member 1 |
115 | 100506658 | 8.2 | 8.9 | 0.1 | 0.1 | 7.401 | 0.0023 | OCLN | occludin |
116 | 8473 | 12.5 | 12.5 | 0.2 | 0.2 | -0.449 | 0.6770 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase |
117 | 10133 | 7.3 | 7.4 | 0.2 | 0.1 | 1.199 | 0.3034 | OPTN | optineurin |
118 | 130497 | 2.5 | 2.9 | 0.1 | 0.8 | 0.899 | 0.4609 | OSR1 | odd-skipped related transciption factor 1 |
119 | 5063 | 2.4 | 2.4 | 0.0 | 0.1 | 0.272 | 0.8037 | PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 |
120 | 23178 | 7.8 | 8.4 | 0.1 | 0.1 | 5.999 | 0.0039 | PASK | PAS domain containing serine/threonine kinase |
121 | 5077 | 2.9 | 3.2 | 0.4 | 0.3 | 1.051 | 0.3563 | PAX3 | paired box 3 |
122 | 5111 | 12.0 | 13.1 | 0.2 | 0.4 | 4.276 | 0.0250 | PCNA | proliferating cell nuclear antigen |
123 | 5163 | 9.3 | 8.6 | 0.3 | 0.0 | -3.924 | 0.0586 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 |
124 | 57026 | 8.0 | 8.3 | 0.3 | 0.4 | 1.120 | 0.3333 | PDXP | pyridoxal (pyridoxine, vitamin B6) phosphatase |
125 | 5585 | 10.0 | 9.7 | 0.4 | 0.1 | -1.130 | 0.3522 | PKN1 | protein kinase N1 |
126 | 5328 | 5.4 | 4.9 | 0.2 | 0.1 | -3.533 | 0.0483 | PLAU | plasminogen activator, urokinase |
127 | 10714 | 10.8 | 11.2 | 0.1 | 0.3 | 2.421 | 0.1027 | POLD3 | polymerase (DNA-directed), delta 3, accessory subunit |
128 | 57804 | 14.6 | 13.8 | 0.3 | 0.4 | -2.989 | 0.0453 | POLD4 | polymerase (DNA-directed), delta 4, accessory subunit |
129 | 84892 | 6.9 | 7.0 | 0.2 | 0.3 | 0.237 | 0.8245 | POMGNT2 | protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) |
130 | 728378 | 13.3 | 13.4 | 0.3 | 0.1 | 0.452 | 0.6847 | POTEF | POTE ankyrin domain family, member F |
131 | 84152 | 2.3 | 2.3 | 0.0 | 0.0 | -0.367 | 0.7344 | PPP1R1B | protein phosphatase 1, regulatory (inhibitor) subunit 1B |
132 | 151242 | 4.2 | 4.2 | 0.1 | 1.0 | -0.086 | 0.9388 | PPP1R1C | protein phosphatase 1, regulatory (inhibitor) subunit 1C |
133 | 5504 | 9.2 | 8.6 | 0.2 | 0.1 | -3.734 | 0.0409 | PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 |
134 | 5516 | 10.2 | 10.1 | 0.1 | 0.2 | -1.541 | 0.2165 | PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme |
135 | 7001 | 12.0 | 12.1 | 0.1 | 0.0 | 3.370 | 0.0339 | PRDX2 | peroxiredoxin 2 |
136 | 112476 | 10.8 | 10.5 | 0.2 | 0.2 | -1.846 | 0.1438 | PRRT2 | proline-rich transmembrane protein 2 |
137 | 5646 | 3.8 | 4.0 | 0.5 | 0.3 | 0.468 | 0.6701 | PRSS3 | protease, serine, 3 |
138 | 5728 | 10.1 | 9.8 | 0.0 | 0.1 | -3.208 | 0.0714 | PTEN | phosphatase and tensin homolog |
139 | 2185 | 9.1 | 8.2 | 0.0 | 0.4 | -4.284 | 0.0472 | PTK2B | protein tyrosine kinase 2 beta |
140 | 5770 | 11.4 | 11.4 | 0.1 | 0.1 | -0.820 | 0.4598 | PTPN1 | protein tyrosine phosphatase, non-receptor type 1 |
141 | 7837 | 11.1 | 11.0 | 0.1 | 0.3 | -0.472 | 0.6722 | PXDN | peroxidasin |
142 | 5879 | 12.6 | 12.7 | 0.3 | 0.0 | 0.507 | 0.6625 | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
143 | 5923 | 3.0 | 2.3 | 1.2 | 0.1 | -0.992 | 0.4255 | RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 |
144 | 5949 | 3.2 | 3.0 | 0.1 | 0.5 | -0.724 | 0.5424 | RBP3 | retinol binding protein 3, interstitial |
145 | 5962 | 5.0 | 6.2 | 0.1 | 0.3 | 6.280 | 0.0160 | RDX | radixin |
146 | 6010 | 2.6 | 3.5 | 0.3 | 0.4 | 3.430 | 0.0353 | RHO | rhodopsin |
147 | 29984 | 10.4 | 10.7 | 0.2 | 0.2 | 2.336 | 0.0799 | RHOD | ras homolog family member D |
148 | 10535 | 13.6 | 13.6 | 0.1 | 0.1 | 0.277 | 0.7967 | RNASEH2A | ribonuclease H2, subunit A |
149 | 6093 | 9.3 | 9.2 | 0.1 | 0.2 | -0.888 | 0.4381 | ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 |
150 | 6198 | 12.0 | 12.2 | 0.2 | 0.2 | 1.256 | 0.2780 | RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
151 | 6261 | 5.8 | 5.9 | 0.4 | 0.1 | 0.448 | 0.6944 | RYR1 | ryanodine receptor 1 (skeletal) |
152 | 27352 | 6.3 | 6.1 | 0.2 | 0.4 | -0.782 | 0.4914 | SGSM3 | small G protein signaling modulator 3 |
153 | 6557 | 2.4 | 2.8 | 0.1 | 0.4 | 1.710 | 0.2248 | SLC12A1 | solute carrier family 12 (sodium/potassium/chloride transporter), member 1 |
154 | 6581 | 2.4 | 2.4 | 0.0 | 0.1 | 0.029 | 0.9782 | SLC22A3 | solute carrier family 22 (organic cation transporter), member 3 |
155 | 788 | 8.3 | 7.5 | 0.1 | 0.4 | -3.731 | 0.0611 | SLC25A20 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
156 | 6541 | 11.0 | 11.2 | 0.5 | 0.2 | 0.587 | 0.6036 | SLC7A1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
157 | 4087 | 4.9 | 4.9 | 0.1 | 0.1 | 0.037 | 0.9726 | SMAD2 | SMAD family member 2 |
158 | 23049 | 10.2 | 10.1 | 0.0 | 0.1 | -1.125 | 0.3669 | SMG1 | SMG1 phosphatidylinositol 3-kinase-related kinase |
159 | 6647 | 16.0 | 16.0 | 0.1 | 0.1 | -0.780 | 0.4796 | SOD1 | superoxide dismutase 1, soluble |
160 | 6657 | 8.7 | 7.1 | 0.4 | 0.4 | -4.799 | 0.0089 | SOX2 | SRY (sex determining region Y)-box 2 |
161 | 6774 | 7.9 | 7.4 | 0.2 | 0.1 | -4.219 | 0.0140 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
162 | 6794 | 11.7 | 11.9 | 0.2 | 0.1 | 1.291 | 0.2927 | STK11 | serine/threonine kinase 11 |
163 | 8428 | 9.2 | 9.4 | 0.1 | 0.2 | 1.401 | 0.2345 | STK24 | serine/threonine kinase 24 |
164 | 11329 | 6.7 | 7.5 | 0.2 | 0.0 | 5.998 | 0.0236 | STK38 | serine/threonine kinase 38 |
165 | 123283 | 6.6 | 7.0 | 0.5 | 0.2 | 1.461 | 0.2427 | TARSL2 | threonyl-tRNA synthetase-like 2 |
166 | 7082 | 9.4 | 10.1 | 0.1 | 0.1 | 10.311 | 0.0007 | TJP1 | tight junction protein 1 |
167 | 11011 | 10.3 | 10.3 | 0.1 | 0.1 | 0.133 | 0.9020 | TLK2 | tousled-like kinase 2 |
168 | 7124 | 3.9 | 4.1 | 2.4 | 0.7 | 0.111 | 0.9206 | TNF | tumor necrosis factor |
169 | 7157 | 7.9 | 7.4 | 0.3 | 0.5 | -1.440 | 0.2378 | TP53 | tumor protein p53 |
170 | 83696 | 11.2 | 10.8 | 0.1 | 0.4 | -1.557 | 0.2423 | TRAPPC9 | trafficking protein particle complex 9 |
171 | 7248 | 7.0 | 6.6 | 0.5 | 0.0 | -1.693 | 0.2299 | TSC1 | tuberous sclerosis 1 |
172 | 51175 | 6.7 | 6.1 | 1.0 | 0.1 | -1.135 | 0.3717 | TUBE1 | tubulin, epsilon 1 |
173 | 3093 | 14.2 | 14.1 | 0.1 | 0.1 | -1.367 | 0.2485 | UBE2K | ubiquitin-conjugating enzyme E2K |
174 | 59286 | 14.6 | 14.9 | 0.3 | 0.1 | 1.525 | 0.2516 | UBL5 | ubiquitin-like 5 |
175 | 23038 | 7.7 | 7.6 | 0.3 | 0.2 | -0.598 | 0.5828 | WDTC1 | WD and tetratricopeptide repeats 1 |
176 | 65266 | 5.7 | 5.7 | 0.1 | 0.2 | -0.097 | 0.9288 | WNK4 | WNK lysine deficient protein kinase 4 |
177 | 7532 | 13.5 | 13.9 | 0.1 | 0.1 | 5.532 | 0.0125 | YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
178 | 158506 | 2.8 | 2.3 | 0.5 | 0.0 | -2.007 | 0.1823 | ZNF645 | zinc finger protein 645 |